These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7289460)

  • 21. [Effect of moxonidine monotherapy and in combination with melatonin on hemodynamic parameters in patients with arterial hypertension].
    Zaslavskaia RM; Komarov FI; Shakirova AN; Teĭblium MM; Akhmetov KZh
    Klin Med (Mosk); 2000; 78(4):41-4. PubMed ID: 10833890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of moxonidine in elderly patients with resistant hypertension.
    Martin U; Hill C; O' Mahony D
    J Clin Pharm Ther; 2005 Oct; 30(5):433-7. PubMed ID: 16164488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure reduction with olmesartan in mild-to-moderate essential hypertension: a planned interim analysis of an open label sub-study in German patients.
    Böhm M; Ewald S;
    Curr Med Res Opin; 2006 Jul; 22(7):1375-80. PubMed ID: 16834836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Losartan potassium as initial therapy in patients with severe hypertension.
    Dunlay MC; Fitzpatrick V; Chrysant S; Francischetti EA; Goldberg AI; Sweet CS
    J Hum Hypertens; 1995 Nov; 9(11):861-7. PubMed ID: 8583463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension.
    Dahlöf B; Keller SE; Makris L; Goldberg AI; Sweet CS; Lim NY
    Am J Hypertens; 1995 Jun; 8(6):578-83. PubMed ID: 7662242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An AT-II blocker in patients with type II diabetes and arterial hypertension].
    Ametov AS; Demidova TIu; Kosykh SA
    Klin Med (Mosk); 2006; 84(2):50-5. PubMed ID: 16613007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of phisiotens for the treatment of arterial hypertension in elderly patients].
    Ostroumova OD; Mamaev VI; Bagramova IuA; Rybkina TE; Kuz'michev IA
    Ter Arkh; 2001; 73(9):17-22. PubMed ID: 11642073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of eprosartan in combination with HCTZ in patients with essential hypertension.
    Sachse A; Verboom CN; Jäger B
    J Hum Hypertens; 2002 Mar; 16(3):169-76. PubMed ID: 11896506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Imidazoline receptor agonists in the practical treatment of hypertension].
    Ol'binskaia LI; Bochenkov IuV; Alekseeva IL
    Ter Arkh; 1998; 70(2):86-8. PubMed ID: 9551585
    [No Abstract]   [Full Text] [Related]  

  • 30. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
    MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS
    Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moxonidine for hypertension.
    Drug Ther Bull; 1997 May; 35(5):33-6. PubMed ID: 9282418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients.
    Robles NR; Martín-Agueda B; López-Muñoz F; Alamo C;
    Int J Clin Pract; 2005 Apr; 59(4):478-84. PubMed ID: 15853868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy of a new angiotensin II type 1 receptor blocker, pratosartan, in hypertensive patients.
    Ogihara T; Saruta T; Shimamoto K; Matsuoka H; Rakugi H
    Hypertens Res; 2008 Feb; 31(2):281-7. PubMed ID: 18360048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of hypersympathycotony in development of arterial hypertension in patients with metabolic syndrome: potential of pathogenetically sound therapy].
    Ametov AS; Demidova TIu; Smagina LV
    Ter Arkh; 2004; 76(12):27-32. PubMed ID: 15724921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of postmenopausal hypertension with moxonidine, a selective imidazoline receptor agonist.
    Kaaja R; Manhem K; Tuomilehto J
    Int J Clin Pract Suppl; 2004 Mar; (139):26-32. PubMed ID: 15117110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New tools, old challenges: the emerging role of angiotensin receptor blockers in the treatment of the systolic hypertension epidemic.
    Feldman RD
    Can J Cardiol; 2004 Oct; 20 Suppl C():5C. PubMed ID: 16807616
    [No Abstract]   [Full Text] [Related]  

  • 38. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
    Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE
    Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinicogenetic aspects of carbohydrate metabolism disorders and efficacy of their correction with moxonidine and metformine in patients with arterial hypertension].
    Kobalava ZhD; Tolkacheva VV; Ignat'ev IV; Glezer MG; Kuzin AI; Karpov IuA; Konradi AO; Zheleznykh EA
    Ter Arkh; 2005; 77(1):46-51. PubMed ID: 15759454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Arterial hypertension in extreme situations].
    Simonenko VB; Fusin AIa; Ovchinnikov IuV; Aleksandrov AS
    Klin Med (Mosk); 2007; 85(10):4-10. PubMed ID: 18154171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.